Royal Medical Center
Royal Medical Center combines hormone and weight care with injectable peptides. A physician-led assessment and named pharmacy are useful, while refill rules and product-specific inclusions need a written explanation.
Review by Leah Garner, clinical-evidence editor · Updated October 2026
The short version
Royal provides more public detail about its pharmacy and assessment than many wellness catalogs. The useful next step is a product-specific care plan. Broad anti-aging language and an all-inclusive banner cannot establish the right treatment or ongoing bill.
Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
Lowest listed: Glutathione injection, from $139/mo
Visit Royal Medical Center →Royal Medical Center advertises hormone therapy, medical weight management and several peptide or wellness prescriptions. Semaglutide and tirzepatide are named weight options. Sermorelin, injectable NAD+ and injectable glutathione have separate product pages. PT-141 and oxytocin are also advertised, with different supply descriptions. This is a medical-service catalog rather than a single standardized subscription. Its Florida clinic address is public, but a clinic address alone does not establish eligibility in every state. Ask whether an appointment can be conducted remotely in your location.
What Royal Medical Center prescribes, by goal
Weight
- SemaglutideFDA-approved
Listed by the seller; no price we hold.
- TirzepatideFDA-approved
Listed by the seller; no price we hold.
Semaglutide and tirzepatide are identified as injectable options within the weight program. The generic GLP-1 starting headline does not say which medicine or term earns it. The clinician should explain the actual formulation, its regulatory status and why it fits the patient’s history. A compounded preparation should not be assumed identical to a branded product.
Sexual health
- PT-141 (bremelanotide)FDA-approved
Listed by the seller; no price we hold.
PT-141 is sold as an injectable treatment, while oxytocin is priced per pill with a minimum purchase. The oxytocin page has inconsistent product wording. Confirm the exact ingredient, strength and route on the prescription before paying. Neither product should be selected solely from a wellness catalog.
Longevity
- NAD+Compounding conditions apply
- Injection (compounded)From $175/mo
- GlutathioneCompounding conditions apply
- Injection (compounded)From $139/mo
Sermorelin and NAD+ are marketed for wellness and aging-related goals. The injection route is public, but a mechanism explanation does not demonstrate improved longevity in Royal patients. A sensible consultation sets an observable goal and a reassessment point rather than promising generalized rejuvenation.
Recovery
- SermorelinCompounding conditions apply
- Injection (compounded)From $175/mo
Glutathione is an injectable offering with a one-month supply label. A concentration on the product page is not the amount supplied or an individualized dose. Ask what clinical problem the treatment addresses and what evidence supports it.
Sleep
- SermorelinCompounding conditions apply
- Injection (compounded)From $175/mo
Each “From” figure is the seller’s own starting price, in the unit the seller states. Where a required fee or a package length changes what one month costs, the smaller line under it is our arithmetic, not a figure the seller prints. Compounded preparations are not FDA-approved.
Who prescribes
A licensed clinician
The about page names one physician, Dagoberto Rodriguez, MD. The advertised process includes physician consultation after reviewing history, laboratory results and a physical examination. These details identify a medical model without promising that the named physician handles every applicant. Confirm the clinician assigned to your state and who reviews later adverse effects. The footer names Belmar Pharma Solutions as the dispensing pharmacy. That improves traceability, although the exact dispensing facility should still appear on the prescription and package.
The service describes detailed bloodwork, a medical-history review, a physical and a physician discussion before an individualized plan. Follow-up and monitoring are included in the weight-program description. The product pages do not publish one common visit schedule across every peptide. General hormone-program FAQs should not automatically be applied to a different prescription. Before enrolling, ask how a symptom reaches the prescriber, whether follow-ups require live appointments and how an urgent concern is handled. An online inquiry is not a guarantee that a prescription will be issued.
Are labs required?
Advertised within the weight program
The headline program describes laboratory testing, and the weight page specifically includes laboratory monitoring and adjustments. That does not establish the exact panel or repeat interval for every separate peptide order. The hormone FAQ discusses its own testing arrangement. Request a product-specific list covering initial tests, later testing and any outside-lab costs. Ask who reviews an abnormal result before treatment proceeds.
Ready to start with Royal Medical Center?
Lowest listed price: Glutathione injection, from $139/mo. Confirm it on the seller’s own site.
What it claims, and what it cites
The public pages connect treatment with weight management, recovery, energy and aging-related benefits. The quality of evidence depends on the ingredient, route and medical indication. Prescription compounding does not itself establish FDA approval. Belmar’s public history also needs precise attribution. FDA’s March 2023 letter concerned Drug Depot, LLC doing business as APS Pharmacy within Belmar Pharma Solutions. FDA’s October 2023 closeout said the cited violations appeared adequately addressed. That record concerns a specific pharmacy facility, not an enforcement finding against Royal or every Belmar prescription.
Other products and treatment claims
- Oxytocin
- We have not yet read its FDA status, so we list no seller for it.
- Hormone replacement and erectile-dysfunction medicines
- These are separate treatment categories and should not be substituted for the peptide prescriptions discussed here.
How it bills
Sermorelin is listed at $175 for one month or $325 for two months. Injectable NAD+ has a $175 one-month option and a separate $375 eight-week program. Injectable glutathione is $139 for one month. Those are different products and commitments, not interchangeable monthly equivalents. The GLP-1 headline starts at $67 a month without assigning it to a particular drug and term. PT-141’s $200 product figure does not establish a monthly supply. Oxytocin is priced per pill with a minimum order rather than a verified monthly course. Broad all-inclusive language needs confirmation for the specific prescription. A universal cancellation deadline, automatic-renewal rule and refund entitlement are not established on these public pages.
For and against
- For: Physician and clinical assessment are described
- For: Dispensing pharmacy publicly identified
- For: Several products have explicit supply terms
- For: Weight-program monitoring is described
- Against: No common peptide follow-up schedule published
- Against: GLP-1 starting price not allocated by medicine
- Against: Oxytocin listing needs formulation clarification
- Against: Universal refund and refill rules unresolved
The evidence behind what it sells
- Semaglutide Side Effects: What the Wegovy Trials and Label Recorded
- Bremelanotide Side Effects: Nausea, Blood Pressure and Skin Darkening
- Glutathione Side Effects: What Injection, IV and Oral Studies Reported
- Sermorelin Side Effects: What the Trials and FDA Record Report
- Tirzepatide Side Effects: What the Zepbound Label and Trials Recorded
- Bremelanotide (PT-141): The FDA Approval and What the Trials Showed
Right for
A patient seeking a clinician-led assessment who will confirm the exact prescription, pharmacy facility and ongoing care arrangement.
Look elsewhere if
Someone expecting a generic GLP-1 headline to identify their medicine or treating wellness claims as proven longevity benefits.
Other sellers for weight
CVS MinuteClinic
Also prescribes Semaglutide, Tirzepatide.
Bodi Envi
Also prescribes Semaglutide, Tirzepatide.
HealthSource
Also prescribes Semaglutide, Tirzepatide.
Royal Medical Center
Frequently asked questions
- Does the GLP-1 starting figure apply to both medicines?
- The public headline does not allocate it between semaglutide and tirzepatide or establish the qualifying plan. Obtain a medicine-specific quote.
- Is the named pharmacy’s warning still open?
- The cited APS Pharmacy case has an October 2023 FDA closeout. It is a facility-specific historical record and does not certify every later prescription.
- Are all peptide follow-ups and labs included?
- Monitoring is described in the weight program, but the exact testing panel and visit schedule for each separate prescription need confirmation.
Sources
- Clinical leadership and assessment pathway
- Weight-program inclusions and monitoring
- Injectable weight medication starting headline
- Sermorelin one- and two-month options
- NAD+ one-month and eight-week programs
- Glutathione supply and concentration
- PT-141 catalog offer
- Oxytocin pill listing
- FDA historical APS Pharmacy warning
- FDA APS Pharmacy corrective-action closeout
See what Royal Medical Center prescribes today
Royal Medical Center sets its own prices, plans and the states it serves. Check them before you start.